Session » Biology and Pathology of Bone and Joint - Poster I

Date: Tuesday, November 15, 2016

Time: 9:00AM-11:00AM

Meeting: 2016 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 2143

A Small Molecule, SM04690, Has Inhibitory Effects on the Wnt Pathway and Inflammation in Vitro, with Potential Implications for the Treatment of Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2125

Aggrecan Degradation Is Not Just Aggrecan Degradation:a Study of the Neo-Epitopes Tege and Args Released from Cartilage upon Aggrecanase Activity

9:00AM-11:00AM: Abstract Number: 2128

Autophagic Clearance of Dysfunctional Mitochondria Requires Parkin in Human Chondrocytes

9:00AM-11:00AM: Abstract Number: 2134

Bone Replaces Cartilage in Non-Weight Bearing Regions of Immobilized Knees

9:00AM-11:00AM: Abstract Number: 2136

CD14 Deficiency Delays Progression of Cartilage Degeneration and Protects Against Early Deficits in Functional Outcomes in a Murine Osteoarthritis Model

9:00AM-11:00AM: Abstract Number: 2126

Cytokine Dependent Effects of Anti-Inflammatory Inhibitors Targeting JAK and p38 on Cartilage Turnover

9:00AM-11:00AM: Abstract Number: 2132

Deficient Autophagy Induces Premature Senescence in Aging and Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2127

Dicam Promotes Proliferation and Hypertrophic Differentiation of Chondrocyte through Indian Hedgehog Signaling of Primary Cilia

9:00AM-11:00AM: Abstract Number: 2120

Discovery of a Small Molecule Inhibitor of the Wnt Pathway (SM04690) As a Potential Treatment for Degenerative Disc Disease

9:00AM-11:00AM: Abstract Number: 2129

Extracellular Adenosine Deficiency Plays a Role in the Pathogenesis of Osteoarthritis (OA) and Adenosine Replacement Prevents Post-Traumatic Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2123

Follistatin-like Protein 1 Is a Potent Regulator of Articular Chondrocytes in Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2139

High Fat Diet Induced Longitudinal Metabolic Changes Contribute to Acceleration of Osteoarthritis in Mice

9:00AM-11:00AM: Abstract Number: 2121

Identification of microRNA-181a-5p and microRNA-4454 As Mediators of Facet Cartilage Degeneration

9:00AM-11:00AM: Abstract Number: 2142

Identification of Novel Molecules Targeting Cartilage Aging As Osteoarthritis Therapeutics

9:00AM-11:00AM: Abstract Number: 2122

KiSS1 Is a Regulator of ADAMTS4 and ADAMTS5 Expression and Is Post-Transcriptionally Regulated By Micro-RNA N105 in Human OA Chondrocytes

9:00AM-11:00AM: Abstract Number: 2135

Knee Osteoarthritis Pain Is Differentially Associated with Tissue Degradation and Joint Inflammation

9:00AM-11:00AM: Abstract Number: 2124

Maintenance of Chondrocyte Phenotypic Stability By TRPC6 Calcium Channel Activity

9:00AM-11:00AM: Abstract Number: 2140

Phenotypic and Functional Characteristics of Exosomes Isolated from Human Osteoarthritis (OA) Synovial Fluid

9:00AM-11:00AM: Abstract Number: 2133

Simulation of Cartilage Damage in Osteoarthritis Using Patient-Derived Induced Pluripotent Stem Cells

9:00AM-11:00AM: Abstract Number: 2137

Subchondral Bone Structure and Pain Behaviors in Collagenase Induced Noninflammatory Monoarthritis in Mice

9:00AM-11:00AM: Abstract Number: 2141

Terminal Uridylyl Transferase ZCCHC6-Dependent Generation of miRNA Diversity in Primary Human Chondrocytes

9:00AM-11:00AM: Abstract Number: 2138

Transcriptional Analysis of Synovial Tissue Reveals Sustained Inflammatory Chemokine Expression Despite Minimal Histopathologic Change in the Destabilization of Medial Meniscus Model of Murine Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2131

Transient Receptor Potential Ankyrin 1 (TRPA1) Is Functionally Expressed in Primary Human Osteoarthritic Chondrocytes and Mediates Cartilage Destruction and Joint Pain in the Mia-Model of Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2130

Unloading Results in Rapid Loss of TGFβ Signaling in Cartilage: Role of Loading-Induced TGF-Β Signaling in Maintenance of Articular Chondrocyte Phenotype?

9:00AM-11:00AM: Abstract Number: 2119

Wogonin, a Plant-Derived Flavonoid, Exert Anti-Inflammatory and Chondroprotective Effects through the Activation Nrf2/HO-1 Signaling in Human OA Chondrocytes

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].